Tumor cells obtained after the treatment schedule (Figure 3D) were harvested, mechanically and enzymatically digested, and stained with anti-CD3, anti-CD8, anti-CD4, and anti-FOXP3 antibodies. Here, CD8A is linked to neoplasm.